Lipocine
LPCN
#10190
Rank
HK$0.14 B
Marketcap
HK$25.44
Share price
2.51%
Change (1 day)
-36.51%
Change (1 year)

Revenue for Lipocine (LPCN)

Revenue in 2025 (TTM): HK$32.72 Million

According to Lipocine's latest financial reports the company's current revenue (TTM ) is HK$32.73 Million. In 2024 the company made a revenue of HK$86.93 Million an increase over the revenue in the year 2023 that were of -HK$22.27 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lipocine from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$32.72 M-62.36%
2024 HK$86.93 M-490.46%
2023 -HK$22.27 Million-669.93%
2022 HK$3.9 M-96.9%
2021 HK$0.12 B
2020 N/A-100%
2019 HK$1.28 M-61.66%
2018 HK$3.35 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Seagen
SGEN
HK$17.89 B 54,564.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$32.34 B 98,705.02%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
HK$0.16 B 412.53%๐Ÿ‡บ๐Ÿ‡ธ USA